News
AbbVie has secured UK marketing authorisation for ELAHERE (mirvetuximab soravtansine), the first antibody-drug conjugate (ADC ...
This month’s executive moves span a diverse range of organisations – from CDMOs and genomics platforms to diagnostics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback